Optimal selective sentinel lymph node dissection in primary malignant melanoma.
about
Progression of cutaneous melanoma: implications for treatmentValidation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases.Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer.The role of sentinel lymph node biopsy in the management of melanomaClinicopathologic analysis of sentinel lymph node mapping in early breast cancer.Sentinel lymph node mapping in colorectal cancer.Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma.Sentinel lymph node biopsy progress in surgical treatment of cancer.Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).Clinical and biological aspects of sentinel node biopsy in malignant melanoma--an update.Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.Lymph node assessment in melanomaCan lymphatic drainage of head and neck melanoma be predicted?The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm.Prognostic implications of thick (>or=4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy.Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience.Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma.Lymphatic mapping and sentinel lymphadenectomy for melanoma.Vital dye is enough for inguinal sentinel lymph node biopsy in melanoma patients.Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients.Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.[Intraoperative labeling of sentinel lymph nodes with a combination of vital dye and radionuclide tracer--results in sentinel lymph node-positive patients].Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma.Is intra-operative gamma probe detection really necessary for inguinal sentinel lymph node biopsy?Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients.Reliability of sentinel lymph node biopsy for staging melanoma.Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure.Sentinel lymph node biopsy: strategies for pathologic examination of the specimen.Sentinel lymph node status in melanoma: a valuable prognostic factor?
P2860
Q27001734-771B05E8-F71C-488C-8B58-10D44C128A8BQ33752235-68DC31FE-DF5F-4620-9565-DB3149F62ACAQ33956833-DF38337A-1683-43F1-97D8-E5B9AEC47077Q34058927-07B8324E-C58B-4DDA-BE17-40E19378D2C6Q34584396-9BC90859-5C3D-4FAD-856F-7A00BC161241Q35129661-7AE2545B-939D-4652-88CF-09617280B8E6Q35155344-9D8F6BEE-00ED-4DDF-859A-CA0E6E068E8BQ35678621-02DA0DE3-CEFE-4D97-B016-FA22FB76ED4EQ35759356-49FF3A39-15E3-4D52-BE64-E7A889D28A65Q35805488-C348560D-C31A-478C-A604-3B1F554E0492Q35895132-C866E5B5-A06C-461D-8FF9-13099A1331CFQ36165408-D2E5B8F4-F044-4540-A754-301945B8FFB1Q36532123-EE17B3FC-A30C-40C1-9758-76B53B90F090Q37344300-EBF40E33-0B6C-4A4C-A1C2-29A71B9B228AQ37835767-B241CE22-1AD9-4895-81D6-C3966DDE47D8Q37944487-AFFE03F3-02E9-4ACD-9136-1B0DF0AE7411Q39797935-AA008102-453F-482F-B02A-E9C8EB0DEB2CQ44175734-973F9D3B-0708-46D1-9512-E2BFD4834A4AQ46001380-E1DE6690-DE83-4269-A0CD-C47DF8416849Q46372462-31318830-158C-4097-BE07-B7AD6C1943B4Q46445275-4C2E74BB-ADD8-4850-979D-435BD91F517AQ46460258-4524078F-F6C1-4254-919E-61712BF493D1Q46954715-B1E5F55A-205A-4D2E-BC3F-8A1BB30D51DBQ46968106-1AE28D0A-6252-4874-B90C-8F4575E41F04Q49264293-96CE9DEB-D880-4740-974C-6A2B2CC4EBA5Q50479955-46159C15-51F4-497F-8042-FB9BBB82D2F8Q50504071-6EF458CE-A35F-4AE3-928C-2777756CE09DQ50507748-6988FE4C-6FBF-4A5A-9937-50E42A5DE20CQ50509234-07331CDE-CCC8-4F24-9B8F-1ADD2B01F712Q50512915-61480FB1-0BA9-4D02-9766-AB400FB36227Q50519767-7E2D9143-3005-4C33-831B-584FAA693022Q50520750-659E55F0-B431-4C18-A160-4AC260273C2DQ51804859-79438BCC-07FE-416E-A408-ABC26714F79C
P2860
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@en
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@nl
type
label
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@en
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@nl
prefLabel
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@en
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@nl
P2093
P1433
P1476
Optimal selective sentinel lymph node dissection in primary malignant melanoma.
@en
P2093
Allen RE Jr
Epstein HD
Kashani-Sabet M
McMillan A
Sagebiel RW
Steinmetz I
P304
666-72; discussion 673
P356
10.1001/ARCHSURG.1997.01430300108021
P577
1997-06-01T00:00:00Z